Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $146.1000 (-1.42%) ($145.8600 - $148.9700) on Tue. Sep. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.15% (three month average) | RSI | 24 | Latest Price | $146.1000(-1.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(53%) SPLV(53%) VYM(49%) IBB(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.575% in a week (0% probabilities). VXX(-34%) VIXM(-31%) USO(-20%) TBT(-17%) GLD(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.575% (StdDev 1.15%) | Hourly BBV | -1.8 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $149.07 | 5 Day Moving Average | $147.43(-0.9%) | 10 Day Moving Average | $147.32(-0.83%) | 20 Day Moving Average | $149.07(-1.99%) | To recent high | -4.1% | To recent low | 10.3% | Market Cap | $257.762b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |